Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

5 Benefits of Digital Signage in Pharmacies and Chemists

Imagine visiting your local pharmacy and seeing a bright display of the newest health and fitness goods. Not only does it look good, but it also puts useful information right in your hands. This shows how powerful digital signage can be!

Digital signage might sound technical, but screens display text, pictures, and videos. When you walk into a shop, these dynamic displays can guide you, inform you, and entertain you. It’s clear why retailers are adopting this technology to improve customer experiences. So, what makes digital signage so beneficial? Let’s explore five key advantages


Grab Attention, Share Information

Gone are the days when signs just sat in shops gathering dust. Today, digital signage in pharmacies features engaging images and dynamic text that capture customers' attention as soon as they walk in. This is an excellent opportunity to showcase new products, promote special offers, and provide essential medical information in a clear and readable format.

Need to remind people to get a flu shot or wash their hands? Digital signage communicates these messages clearly and effectively. It's also an ideal platform for highlighting initiatives like the Pharmacy First scheme and Healthy Living Pharmacies, emphasising community health and well-being.

Boost Sales and Promote Services

Digital signage isn’t just for sharing information; it’s a powerful tool to boost sales. Highlight seasonal products like allergy relief during hay fever season or flu shots as winter approaches. Update promotions quickly to match specific times of the day or week with ease.

Additionally, you can advertise other pharmacy services, such as medication reviews and travel vaccinations, or even sell sponsorship space to pharmaceutical companies.

Reduce Waiting Time Woes

Waiting in line can be frustrating, but digital signage can help ease the wait by entertaining and informing customers. Displays showing news, health tips, or video clips can make the time pass faster. Additionally, providing estimated wait times on digital screens keeps customers informed and reduces anxiety.

Customer Experience

Digital signage goes beyond advertising and information dissemination; it significantly enhances the customer experience. Pharmacies can display health tips, short video guides on medication usage, or local health news, positioning themselves as a trusted source of information and fostering a sense of community care.

Streamline Staff Communication

Digital signage is also a valuable tool for internal communication. Use it to display important announcements, training updates, or staff schedules, ensuring everyone is informed from a single, centralised platform. This approach saves time and ensures consistency in communication

Conclusion

Digital signage solutions are a versatile and powerful asset for pharmacies. They can transform the customer experience, increase sales, reduce waiting times, and enhance staff communication.

Whether you are establishing a new facility or renovating an existing one, digital signage is one approach to improve the patient experience and give a more effective option for reaching consumers.

As you explore ways to serve your community better, remember that innovative solutions could be just a screen away. Take advantage of every opportunity to engage with your audience.

More For You

Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less
NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less